Month: November 2011

The Spanish society of physicians in primary care (SEMERGEN) donates 300 meals to economic kitchen of Oviedo.

|

The society Spanish of doctors in primary care (SEMERGEN) donates 300 meals to economic kitchen Oviedo.

the delivery is made moments prior to the closing of its 33 banquet Congress national.

Oviedo, November of 2011- the Spanish society of physicians primary care (SEMERGEN) donated close to 300 meals to economic of Oviedo hours before the celebration of the closing of 33 banquet cuisine Congress SEMERGEN, which met on Saturday, 5 November, more than 3,000 guests in the Palacio de Congresos “ Ciudad de Oviedo ”. Dr. Manuel Amadeo Fernández Barrial, Chairman of the Organising Committee of the Conference and SEMERGEN Asturias, has highlighted the work of this charity, directed by the Sisters of charity, which this year expects to give more than 100,000 meals. “ Are very proud with this help ”, says.

The economic kitchen of Oviedo was founded in 1888 by representatives of different sectors of the city at a time in which Asturias lived one of the worst storms of snow that they remember and whose effects particularly impacted between layers the Oviedo population poorest. Its main objectives are as follows: make it easier for those who require it healthy and nutritious food at affordable price; meet, to the extent that resources permit, intellectual and moral order needs; and to provide food to people displaced from their home due to studies, work or any other circumstances which justify the need for attention.

Spanish society of physicians in primary care (SEMERGEN)

SEMERGEN is the pioneer of primary care in Spain, with 37 years of experience. He was established with the primary objective of promoting family medicine through the maintenance and improvement of the professional competence of physicians, promoting research and facilitating the continuing education of health care provider in order to maintain the quality in the care of the health of citizens.

Currently, SEMERGEN has more than ten thousand members, and is present in all professional areas, being the scientific society that brings together the most doctors work in primary care.

It has 17 regional delegations and held democratic elections every 4 years. SEMERGEN Foundation was established in 1999. This year it had held its thirty-third Congress, as well as dozens of regional conferences.

Read More

The Spaniards are 33,57 sick days per year on average.

|

The Spaniards are 33,57 sick days per year in average.

Spain, November of 2011- the average sick leave days lost to Spain common contingencies stands at 33,57 days, according to data published by the addition of mutual’s work and professional diseases of the Social Security (MATEPSS), in data accumulated up to the month of August. This amount represents a decrease of 5.9% in the number of casualties recorded in the past year and is a quantity 3.03 per cent higher than the number of casualties recorded by accident at work or occupational disease.

On the other hand, the processes initiated during this period average stands at 231.639, which is a figure 4.4 times greater than the number of casualties recorded by professional contingencies.

Women are of low 36,01 days a year for joint contingency, while men do 31,15. On the contrary, men suffer more from job losses for contingency professional, being away from work an average of 32,72 days, while women do 32.23.

León is the municipality which additional working days lost from Spain disease or common accident 51,32 average of sick leave days; on the opposite side meets Navarra, 22,98 days lost to the year

The law medical group offers this data because it takes since 1978 fighting for the rights of those suffering from a medical condition which prevents them from working, because that is the only Center in Spain in offering technical, medical and legal advice to ensure a favorable outcome in the processing of Social security pensionsat the time that the temporary disability becomes permanent disability.

Read More

Adequate control of diabetes and eye reviews delayed the appearance of diabetic retinopathy.

|

Adequate control of diabetes and eye reviews delayed the appearance of retinopathy diabetic.

14 November, day world of Diabetes.

Barcelona, November 2011- more than half of persons suffering from diabetes for more than 15 years presents any signs of diabetic retinopathy, one of the main causes of severe loss of vision in developed countries. For this reason, and coinciding with the World Diabetes Day, specialists in retina of IMO offered last Monday, November 14, a Conference on Diabetes and vision, which sought to educate patients and people in general about the importance of prevention and the strict control of the disease and vision in this group.

According to the Department of retinta of IMO, diabetic retinopathy is one of the main causes of severe loss of vision in the Western world. Only in Catalonia, it is estimated that around 2% of the diabetic population presents degrees of retinopathy advanced legal blindness or total vision loss. Although patients with diabetes have up to 25 times more likely to total loss of vision that persons who do not have the disease, visual damage resulting from diabetes does not have why to become serious. This will depend on the degree of severity of diabetes, the time elapsed since the beginning of the disease and the level of control by the patient. Diagnosis and early treatment are therefore basic, according to experts.

The main preventive measures of diabetic patients to avoid or delay the onset of diabetic retinopathy are tight control of glucose in the blood, of blood pressure and cholesterol and avoiding tobacco. Also essential thorough ophthalmologic monitoring, as usually, diabetic retinopathy does not cause symptoms until the injury is severe.

The ophthalmic review in type 1 diabetics should be at the 3-5 years of diagnosis, while type 2 diabetics should begin Baviera revisions from the moment in which the disease is diagnosed. After this first test, all patients should undergo an ophthalmological annual review should not notice any injury, especially groups of pregnant women and people with a poor metabolic control of diabetes. An ophthalmologist will propose revisions to control based on the loss of vision of each patient. In any case, it is desirable to diagnose retinopathy rather than appear symptoms.

diabetic retinopathy

diabetic retinopathy occurs because the walls of the retinal vessels are altered and become more permeable as a result of high levels of blood glucose. These vessels are no longer relevant and allow the passage of fluid into the extracellular space. Diabetic retinopathy begins to manifest itself with small lesions (like capillary dilatations or micro aneurysms) and loss of fluid in the retina. This causes a ponding in the retina and whether it extends to the macula, may cause edema macular (one of the main causes of decreased visual acuity in diabetic patients).

In more advanced cases, there is what is known as “ proliferating diabetic retinopathy ”, the most serious retinal table related to diabetes, which affects 20% of people with diabetes and can lead to a severe loss of vision. Called proliferating because it is produced by the proliferation of new blood vessels. These stem haemorrhage in vitreous space, a gelatinous and transparent fabric, that fills the eyeball. To bleed the vessels of the retina, the vitreous becomes opaque and causes decreased vision, generally occurring sharply. Current treatments – photocoagulation lasers, intravítreas injection or vitrectomy – manage to stop the progression of the disease and can improve visual prognosis of the patient. Other Visual complications associated with diabetes are edema and macular, the retinal detachment, glaucoma or cataracts.

Two of the specialists in retina of IMO, Dr. Borja Corcóstegui and Dr. Carlos Mateo, offer some clues to diabetic retinopathy on the following links:

the importance of early diagnosis (Dr Borja Corcóstegui)

metabolic decompensation of the diabetic is a “cheque” paid to long term (Dr. Carlos Mateo)

Read More

VitalAire presented the first results of the project REPOCA in the II International Symposium on “COPD and smoking” which took place in Caceres on 10 and 11 November.

|

VitalAire presented the first results of the project REPOCA in the II International Symposium “ COPD and tobacco ” which took place in Caceres on 10 and 11 November.

is a service developed with the aim of improving the quality of life and reduce hospitalizations for COPD patients, representing most of the cost of the disease.

Madrid, November of 2011- the II International Symposium “ COPD and smoking: diagnóstico-terapéutica update and future perspectives ” which was held on 10 and 11 November in Cáceres, had the presence of Javier González Cappa, responsible for new developments of VitalAire. González Cappa presented last Friday from 14.00 hours, the first results of the project REPOCA at the Cultural complex “ San Francisco ” de Cáceres.

Currently, COPD (obstructive Chronic pulmonary disease) affects more than 210 million people and represents the 4th cause of death globally, providing that it becomes the 3rd in 2030.

Currently, around more than one million and a half people are treated for this disease in Spain, of which between 20-30% are frecuentadores sick. In words of Javier González Cappa, “ VitalAire boasts more than 30 years of experience that have served to check the effectiveness of the treatment of COPD is a good patient education, as well as the need to monitor and to share with doctors and public administrations compliance ”.

The service developed by VitalAire, REPOCA, is aimed at frecuentadores COPD patients, i.e., aimed at those who do not need even external inputs of oxygen, because they are frequent acute episodes and admissions that impair their quality of life and its environment. This project is aimed at strengthening the education of the patient in the management of COPD symptoms and thus improve as much as possible, their quality of life.

REPOCA was born with the desire to give efficient answers to patients, showing them how to control the previous signs of the disease and thus avoid income increased their quality of life and, most likely, their prospects for survival.

The II International Symposium “ COPD and smoking: diagnóstico-terapéutica update and future prospects ” has been designed to any healthcare professional interested in tackling smoking or COPD.

Air Liquide is the world leader in gases for industry, health and the environment and is present in 80 countries with 43,600 employees. Oxygen, nitrogen, hydrogen and the noble gases are at the heart of the activity of Air Liquide since its creation in 1902. From these molecules, Air Liquide continually reinvents its business to anticipate the challenges of their present and future markets. The Group innovates to enable progress, at the time that excels in jointly achieving dynamic growth and regularity in its results
innovative technologies for limiting emissions, reduce energy consumption in industry, put in value natural resources or develop the energies of tomorrow, such as hydrogen, biofuels and photovoltaics … oxygen for hospitals, home care, contribute to the fight against nosocomial diseases … Air Liquide combines numerous products with various technologies to develop applications and services with high added value for its clients and society.

A partner for the long term. The Group relies on the commitment of its employees, the confidence of its customers and the support of its shareholders to develop a long-term focus on competitive growth vision. The diversity of its teams, activities, markets and geographical presence ensures the soundness and sustainability of their development, and strengthens its ability to continuously conquer new territories to overcome its own boundaries, and build their future.

Air Liquide explores the best that the air can offer to preserve life, maintaining a dynamic of sustainable development. In 2010, its turnover reached 13,500 million EUR of which more than 80% out of France. Air Liquide is listed on the stock exchange of Euronext Paris (compartment A) and part of the CAC indexes 40 et Dow Jones Euro Stoxx 50.

Read More

The Community invests more than 36 million euros in vaccines for adults and children.

|

The Community invests more than 36 million euros in vaccines for adults and children.
for the calendars of childhood immunizations and the adult.

-the Governing Council authorized the acquisition of more than 1.3 million doses in 14 batches, for 2012

-Vaccines will be supplied to about 660 centres authorized public and private health network

Madrid, November of 2011- the Council of Government today approved the procedure for the acquisition of vaccines for the campaign for children and adults, within their respective calendars of 2012, for an amount of 36.674.833 euros.

The vaccines will be supplied to about 660 vaccination centres belonging to the authorized public and private health network.

They will acquire in total 1.370.100 doses of vaccines in 14 batches. Lots correspond to different types and forms of vaccines, including injectable polio, hepatitis b child, HB hemodializados, difteria-t̩tanos Рwhooping cough, triple viral (measles, rubella, mumps), chickenpox, and Pneumococcus.

Immunization is a preventive intervention performed on susceptible to disease, healthy population using vaccines developed with the most modern technologies and that have amply demonstrated its safety and efficacy. It is the best measure of prevention and protection in the most appropriate age.

The children’s immunization schedule begins with the birth of the child and the administration of the vaccine against hepatitis B, and ends at age 14 with diptheria and papillomavirus vaccines. The community of Madrid was the first to include in its calendar infant pneumococcal vaccine.

Adults calendar has a set of guidelines to be followed depending on the age of the person. In general terms, all adults with incomplete vaccination or not vaccinated in childhood should be completed its vaccination scheme.

In the community of Madrid, routine immunization programmes have always had a very important follow-up, as a result of the confidence that both the population and health professionals have in vaccines. This situation has led to achieve vaccine coverage very high, especially important in the early years of life. The result has been the control and elimination of communicable diseases front that is available of a vaccine effective

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips